A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study.
Sarah VerrecchiaFredéric ChiambarettaLaurent KodjikianYasemin NakouriHussam El ChehabThibaud MathisYannis BadriRoman ChudzinskiAntoine LevronMayeul ChaperonEmilie AgardPierre PradatCorinne DotPublished in: Acta ophthalmologica (2021)
Our results confirm the impairment of the ocular surface and quality of life immediately after an IVTI. These results suggest 3 levels of action to improve the immediate tolerance: improving the basal status of the ocular surface, reducing the contact time with povidone-iodine that might be toxic to the surface, and improving immediate post-IVTI treatment.